SCHEMBL17243734

SCHEMBL17243734

CCCC(=O)Oc1ccc(/C=C/c2cc(C)cc(O)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCL9 O00512 1/20 0.46
▸ CTNNB1 P35222 1/20 0.46
▸ KMT2A Q03164 7/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ LMNA P02545 4/20 0.46
▸ MAPT P10636 4/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ TTR P02766 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ PTGS2 P35354 4/20 0.45
▸ PTGS1 P23219 2/20 0.45
▸ CYP1A1 P04798 2/20 0.45
▸ CYP1B1 Q16678 2/20 0.45
▸ ALOX12 P18054 1/20 0.45
▸ ALB P02768 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.42
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17243982 0.92 LMNA (0.54) BCL9CTNNB1KMT2AKDM4ELMNA
SCHEMBL14003975 0.88 KMT2A (0.48) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL13869475 0.88 KMT2A (0.58) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL13345755 0.86 KMT2A (0.44) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL13239069 0.85 HDAC8 (0.43) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL20581562 0.84 KMT2A (0.64) BCL9CTNNB1KMT2AKDM4ELMNA
SCHEMBL19873148 0.83 KMT2A (0.53) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL1042498 0.83 PTGS2 (0.56) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL19873140 0.82 KMT2A (0.55) KMT2AKDM4ELMNAMAPTMEN1
SCHEMBL18471992 0.81 LMNA (0.69) KMT2AKDM4ELMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9180111-B2 Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof CARDAX PHARMA, INC. (US) 2015-11-10 — — US disclosed
Send feedback